NS-001: Characterization and management of oral and dermatological toxicities in patients receiving the CD3 X GPRC5D bispecific antibody talquetamab for the treatment of relapsed/refractory multiple myeloma
Titel:
NS-001: Characterization and management of oral and dermatological toxicities in patients receiving the CD3 X GPRC5D bispecific antibody talquetamab for the treatment of relapsed/refractory multiple myeloma
Auteur:
Aronson, Elizabeth Purcell, Kiah Aponte, Annel Louw, Karen Catamero, Donna Lamb, Angela Kirke, Diana Lucas, Aimee Jagannath, Sundar Chari, Ajai